ÌìÏÂÉúÃü¿ÆÑ§Ç°Ñض¯Ì¬Öܱ¨£¨ÎåÊ®£©
£¨7.25-7.31/2011£©
Ò»¾º¼¼¹ú¼Ê¼¯ÍÅ:ÌÕ¹úÐÂ
Ö÷ÒªÄÚÈÝ£º×ÔÉíÃâÒßÐÔθÑ×ÓëÓÄÃÅÂÝÐý¸Ë¾úѬȾÎ޹أ»ÐÛÐÔ¼¤ËØÍƶ¯ÁËÒ»²¿·ÖÅ®ÐÔÈéÏÙ°©µÄÉú³¤£»¶¨Á¿µÄ±í¹ÛÒÅ´«Ó°Ï󱳺óµÄ»ùÓÚ¶àÊáµÄ¿ª¹Ø£»ÒÅ´«ÐÔÈéÏÙ°©ÒÅ´«Ô¤ÆÚÓë¶ËÁ£Ëõ¶ÌÏà¹Ø£»ÈËÌåÓÕµ¼¶àÐÑĿϸ°û²ØÓÐÖ²¡ÐÔÏßÁ£ÌåDNAÍ»±ä¡£
½¹µã¶¯Ì¬£º×ÔÉíÃâÒßÐÔθÑ×ÓëÓÄÃÅÂÝÐý¸Ë¾úѬȾÎ޹ء£
1. ×ÔÉíÃâÒßÐÔθÑ×ÓëÓÄÃÅÂÝÐý¸Ë¾úѬȾÎÞ¹Ø
¡¾¶¯Ì¬¡¿
ÍÁ¶úÆä¿ÆÑ§¼Ò×î½üÑо¿ÁËÓÄÃÅÂÝÐý¸Ë¾ú£¨Hp£©Óë×ÔÉíÃâÒßÐÔθÑ×Ö®¼äµÄ¹ØÏµ¡£¾ÓÉ×é֯ѧºÍѪÇåѧ¼ì²é£¬82¸öHpÑôÐÔ»¼ÕߺÍ96¸öHpÒõÐÔ»¼Õß¼ÓÈëÁËÊÔÑé¡£ËùÓл¼Õß¶¼½ÓÊÜÁËÉÏÏû»¯µÀÄÚ¿ú¾µ¼ì²é¡£´Óθñ¼¡¢Î¸ÌåºÍθ´óÍäÈ¡Èý¸ö»î×éÖ¯Ñù±¾×öÇÐÆ¬¼ì²é¡£È¡ÑªÇåÑù±¾¼ì²é¿¹Î¸±Úϸ°û¿¹Ì壬¿¹Hp IgGºÍάÉúËØB12¡£ÓÃѧÉútÄ¥Á·ºÍ¿¨·½Ä¥Á·¾ÙÐÐͳ¼ÆÆÊÎö¡£P<0.05ΪÓÐͳ¼ÆÑ§ÒâÒåµÄÏÔÖø²î±ð¡£82¸öHpÑôÐÔ»¼Õ߯½¾ùÄêËê45.1¡À15.1Ëê¡£HpÑôÐÔ×éÓëÒõÐÔ×éÖ®¼äÔÚÄêËê¡¢ÐÔ±ðºÍθÌåήËõÇéÐÎÉÏÎÞÏÔÖøÐÔ²î±ð¡£11¸öHpÑôÐÔ»¼Õߣ¨13.4%£©ºÍ14¸öHpÒõÐÔ»¼Õߣ¨14.6%£©¿¹Î¸±Úϸ°û¿¹ÌåÑôÐÔ¡£Á½×éÖ®¼äÎÞͳ¼ÆÑ§ÒâÒåµÄÏÔÖøÐÔ²î±ð£¨p>0.05£©¡£±Úϸ°û¿¹ÌåÑôÐÔºÍÒõÐÔ×éÖ®¼äÔÚÏû»¯µÀÄÚ¿ú¾µ¼ì²éЧ¹û¡¢Î¸ñ¼Î¸Ìå·¢Ñ׺ÍήËõ·½Ãæ¾ùÎÞÏÔÖøÐÔ²î±ð£¨p>0.05£©¡£¸ÃÑо¿Ã»Óз¢Ã÷ÔÚÓÄÃÅÂÝÐý¸Ë¾úѬȾºÍ×ÔÉíÃâÒßÐÔθÑ×±ê¼Ç¿¹Î¸±Úϸ°û¿¹ÌåÖ®¼äÓÐÈκιØÁª¡£»¹ÐèÒªºã¾ÃËæ·ÃHpѬȾ»¼Õߺͼì²â¸ù³ýHpÓë×ÔÉíÃâÒßÐÔήËõÐÔθÑ×Ö®¼äµÄ¹ØÏµ¡£
¡¾µãÆÀ¡¿
¡¡ÍÁ¶úÆä¿ÆÑ§¼ÒµÄÁÙ´²Ñо¿Ð§¹ûΪ×ÔÉíÃâÒßÐÔθÑ×ÓëÓÄÃÅÂÝÐý¸Ë¾úѬȾÎÞÒ»¶¨ÁªÏµÌṩÁËеÄÖ¤¾Ý¡£
¡¾²Î¿¼ÂÛÎÄ¡¿Turk J Gastroenterol. 2011;22(2):134-8.
Is there a relationship between Helicobacter pylori and gastric autoimmunity
Erdoğan A, Yilmaz U.
Background/aims: Helicobacter pylori-associated corpus atrophy and autoimmune gastric atrophy share similar histopathologic and clinical aspects. In our study, the relation between Helicobacter pylori and autoimmune gastritis was investigated. Methods: Eighty-two consecutive histologically and serologically Helicobacter pylori-positive and 96 Helicobacter pylori-negative patients were enrolled in the study. All patients underwent diagnostic upper esophagogastroduodenal endoscopy. Three biopsy specimens from the antrum and corpus greater curvature were obtained for histologic evaluation. Serum samples were collected for detection of anti-parietal cell antibody, anti-Helicobacter pylori IgG and vitamin B12. Statistical analyses were determined with Student t-test and chi-square test. Statistical significance was determined with a p-value <0.05. Results: Of 82 Helicobacter pylori-positive patients, 45 were female and 36 were male, with a mean age 45.1 ¡À 15.1. There was no significant difference in age, gender and corpus atrophy between the Helicobacter pylori-positive and -negative groups. Eleven Helicobacter pylori-positive patients (13.4%) and 14 (14.6%) Helicobacter pylori-negative patients were positive for anti-parietal cell antibody; the difference between the two groups was not statistically significant (p>0.05). Differences in esophagogastroduodenal endoscopy findings, antrum and corpus inflammation, antrum and corpus atrophy, and vitamin B12 levels were found to be insignificant between parietal cell antibody-positive and -negative groups (p>0.05). Conclusions: We did not find any relation between Helicobacter pylori infection and anti-parietal cell antibody, a marker of autoimmune gastritis. Long-term follow-up of Helicobacter pylori-infected patients and also determination of the relation between eradication of Helicobacter pylori and autoimmune atrophic gastritis are needed.
2. ÐÛÐÔ¼¤ËØÍƶ¯ÁËÒ»²¿·ÖÅ®ÐÔÈéÏÙ°©µÄÉú³¤
¡¾¶¯Ì¬¡¿
Õë¶Ô´Æ¼¤ËØÊÜÌ壨ER£©µÄ¼¤ËØÁÆ·¨¹ØÓڴƼ¤ËØÊÜÌåÒõÐÔµÄÄÇ25%µ½30%²¡ÈËÎÞЧ¡£ÔÚ60%µ½70%µÄ²¡ÈËÖлá±í´ïÐÛÐÔ¼¤ËØÊÜÌ壨AR£©£¬ÓëER״̬Î޹ء£ÐÛÐÔ¼¤ËغÍARÔõÑùµ÷ÀíÈéÏÙ°©Éú³¤»¹ºÜ²»ÇåÎú¡£ÃÀ¹ú¿ÆÑ§¼Ò×î½ü·¢Ã÷ÔÚERÒõÐÔ²¢¹ý±í´ïHER2µÄÈéÏÙÖ×ÁöÖÐARÐí¶à£¬Í¨Ì«¹ýÎöER-/HER2+ µÄÈéÏÙÖ×ÁöÖеÄAR ˳·´×éºÍÐÛÐÔ¼¤Ëص÷ÀíµÄ»ùÒò±í´ï£¬ËûÃÇ·¢Ã÷ARͨ¹ýÖ±½ÓÓÕµ¼×ªÂ¼WNT7BºÍHER3½éµ¼¼¤»îÁËÅäÌåÒÀÀµµÄWntºÍHER2ÐźÅͨ·¡£×¨ÃÅÕë¶ÔAR¡¢Wnt»òHER2ÐźÅËðº¦ÁËÐÛÐÔ¼¤Ëش̼¤µÄÖ×Áöϸ°ûÉú³¤ÕâÒ»Õ÷ÏóÌáÐÑÁ˶ÔER-/HER2+ ÈéÏÙÖ×ÁöµÄDZÔÚÖÎÁÆÒªÁì¡£ÕâÒ»Ñо¿·¢Ã÷ÁËÕë¶Ô·Ç´Æ¼¤ËØÍƶ¯µÄÈéÏÙ°©µÄ½ø¹¥µã¡£
¡¾µãÆÀ¡¿
¸ÃÑо¿·¢Ã÷Á˳ýÁ˴Ƽ¤ËØÓëÈéÏÙ°©Óйأ¬ÐÛÐÔ¼¤ËØÓëÈéÏÙ°©Ò²ÓйØÏµ¡£ÎªÖÎÁƴƼ¤ËØÊÜÌåÒõÐÔµÄÈéÏÙ°©»¼ÕßµÄÑо¿¿ª·¢ÁËõè¾¶¡£
¡¾²Î¿¼ÂÛÎÄ¡¿Cancer Cell, 2011; 20 (1): 119-131 DOI: 10.1016/j.ccr.2011.05.026
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Min Ni, Yiwen Chen, Elgene Lim, et al.
Endocrine therapies for breast cancer that target the estrogen receptor (ER) are ineffective in the 25% 30% of cases that are ER negative (ER ). Androgen receptor (AR) is expressed in 60% 70% of breast tumors, independent of ER status. How androgens and AR regulate breast cancer growth remains largely unknown. We find that AR is enriched in ER breast tumors that overexpress HER2. Through analysis of the AR cistrome and androgen-regulated gene expression in ER /HER2+ breast cancers we find that AR mediates ligand-dependent activation of Wnt and HER2 signaling pathways through direct transcriptional induction of WNT7B and HER3. Specific targeting of AR, Wnt or HER2 signaling impairs androgen-stimulated tumor cell growth suggesting potential therapeutic approaches for ER /HER2+ breast cancers.
3. ¶¨Á¿µÄ±í¹ÛÒÅ´«Ó°Ï󱳺óµÄ»ùÓÚ¶àÊáµÄ¿ª¹Ø
¡¾¶¯Ì¬¡¿
¡¡¡¡ÊؾɵĶàÊáÒÖÖÆ¸´ºÏÎï2£¨PRC2£©¾ÙÐеÄ×éÂѰ×3Àµ°±Ëá27Èý¼×»ù»¯£¨H3K27me3£©ÓëÎȹ̵ıí¹ÛÒÅ´«¾²Ä¬Óйء£¶ÔPRC2ÓÕµ¼µÄ»ùÒò¾²Ä¬ÒÑÓÐÐí¶àÏàʶ£¬µ«Òªº¦ÎÊÌâÕվɹØÓÚËüµÄȺ¼¯ºÍÎȹÌÐÔ¡£Ö²Îï¶Ô¶¬ÌìµÄ¸ÐÖªºÍÓ°Ï󣬼´´º»¯Õ÷Ïó£¬ÔÚÄâÄϽæÊÇÒ»¸öÉæ¼°»ùÓÚPRC2µÄ»¨ÒÖÖÆ×ÓFLCµÄ¾ÁϬµÄ¾µä±í¹ÛÒÅ´«Àú³Ì¡£´º»¯Õ÷Ïó»ºÂýµÄ¶¯Á¦Ñ§ÌåÏÖΪÔÚÀäÌìÐèÊýÖÜʱ¼ä²Å»ª±¬·¢£¬ÔÚ½ÓÏÂÀ´µÄůÈÕ×Ó±¬·¢Ò»¶¨Ë®Æ½µÄ¶¨Á¿È¡¾öÓÚ֮ǰÀäÌ쳤¶ÈµÄÎȹ̵ÄFLC¾²Ä¬¡£ÕâÐ©ÌØµãʹ´º»¯Õ÷Ïó³ÉΪÀíÏëµÄÊÔÑéϵͳÀ´Ñо¿±í¹ÛÒÅ´«×´Ì¬µÄά³ÖºÍת»»¡£Ó¢¹ú¿ÆÑ§¼ÒʹÓÃÊýѧģ×Ó¡¢È¾É«ÖÊÃâÒß³ÁµíºÍFLC:GUS±¨¸æÆÊÎö£¬ËµÃ÷ÎúÔÚϸ°ûÊýĿȡ¾öÓÚ֮ǰÀäÌìÊýµÄÒ»¸öϸ°ûÑÇȺÖдº»¯Õ÷ÏóµÄÊýÄ¿»¯ÌìÐÔ±¬·¢ÓÚH3K27me3½éµ¼µÄůÌìFLC¾²Ä¬¡£ÔÚÀäÌìʱ´ú£¬ÔÚFLCÉϽô¿¿Èº¼¯ÇøÓòµÄµØ·½H3K27me3ˮͨ³£½¥ÔöÌí¡£ÔÚÀäÌì¿¢ÊÂʱ£¬Êý×ÖÄ£ÄâÕ¹ÍûÕâÑùµÄÒ»¸öȺ¼¯ÇøÓòÄܹ»×ª»»¸öÌåλÖõÄË«ÎÈ̬µÄ±í¹ÛÒÅ´«×´Ì¬£¬Í¨¹ý¾²Ä¬È¡¾öÓÚÀäÌì̻¶ʱ³¤µÄH3K27me3±ê¼Ç¶ø¿ÉÄܺ¸ÇÕû¸öFLC¡£Òò´Ë£¬¸ÃÄ£×ÓÕ¹ÍûÁËÔÚµ¥¸öϸ°ûÖÐFLC»ùÒò±í´ïµÄÒ»ÖÖË«ÎÈ̬ģʽ£¬Ò»ÖÖÓÃFLC:GUS±¨¸æÏµÍ³È·ÈϵÄÕ¹Íû¡£¸ÃÑо¿Ìá³öµÄת»»»úÖÆ£¬Éæ¼°Ò»¸öÏà·´×÷ÓÃ×éÂѰ×ÐÞÊεľֲ¿Èº¼¯£¬ºÜ¿ÉÄÜÓëÆÕ±éµÄ±í¹ÛÒÅ´«ÖØ×éÓйء£
¡¾µãÆÀ¡¿
¡¡¸ÃÑо¿Ú¹ÊÍÁËÉúÎïÌåÔõÑù¶ÔһЩת±äµÄÇéÐÎÌõ¼þÐγÉÉúÎïѧӰÏ󣬷¢Ã÷Ó°Ïó»úÖÆÊÇÒ»ÀàÉúÎïѧ¿ª¹Ø²¢ÄÜÒÅ´«¸ø×ÓÅ®µÄ±í¹Ûµ÷¿Ø¡£
¡¾²Î¿¼ÂÛÎÄ¡¿Nature, 2011; DOI:10.1038/nature10241
A Polycomb-based switch underlying quantitative epigenetic memory
Andrew Angel, Jie Song, Caroline Dean, Martin Howard.
The conserved Polycomb repressive complex 2 (PRC2) generates trimethylation of histone 3 lysine 27 (H3K27me3), a modification associated with stable epigenetic silencing. Much is known about PRC2-induced silencing but key questions remain concerning its nucleation and stability. Vernalization, the perception and memory of winter in plants, is a classic epigenetic process that, in Arabidopsis, involves PRC2-based silencing of the floral repressor FLC. The slow dynamics of vernalization, taking place over weeks in the cold, generate a level of stable silencing of FLC in the subsequent warm that depends quantitatively on the length of the prior cold. These features make vernalization an ideal experimental system to investigate both the maintenance of epigenetic states and the switching between t em. Here, using mathematical modelling, chromatin immunoprecipitation and an FLC:GUS reporter assay, we show that the quantitative nature of vernalization is generated by H3K27me3-mediated FLC silencing in the warm in a subpopulation of cells whose number depends on the length of the prior cold. During the cold, H3K27me3 levels progressively increase at a tightly localized nucleation region within FLC. At the end of the cold, numerical simulations predict that such a nucleation region is capable of switching the bistable epigenetic state of an individual locus, with the probability of overall FLC coverage by silencing H3K27me3 marks depending on the length of cold exposure. Thus, the model predicts a bistable pattern of FLC gene expression in individual cells, a prediction we verify using the FLC:GUS reporter system. Our proposed switching mechanism, involving the local nucleation of an opposing histone modification, is likely to be widely relevant in epigenetic reprogramming.
4. ÒÅ´«ÐÔÈéÏÙ°©ÒÅ´«Ô¤ÆÚÓë¶ËÁ£Ëõ¶ÌÏà¹Ø
¡¾¶¯Ì¬¡¿
Ô½À´Ô½¶àµÄÖ¤¾ÝÅú×¢¶ÌµÄ¶ËÁ£ºÍÏìÓ¦µÄ»ùÒò²»ÎȹÌÐÔ¶Ôϸ°û¶ñÐÔת±ä¸ºÓÐÔðÈΡ£¼Ò×åÐÔÈéÏÙ°©ÒÑÊӲ쵽ÓÐÒÅ´«ÐÔ¡£Î÷°àÑÀµÄ¿ÆÑ§¼Ò¼ÙÉèÒý·¢´Ë²¡µÄ»ùÒòȱÏÝ»áÓ°Ïì¶ËÁ£µÄά»¤µ¼Ö¶ËÁ£Ëõ¶Ì£¬Ñо¿Á˼Ò×åÐÔÈéÏÙ°©²¡È˵ĶËÁ£³¤¶È¡£ËûÃÇÊ×ÏÈÑо¿ÁË623¸öÈéÏÙ°©¼Ò×åÖÐĸٶԵķ¢²¡ÄêËêÔ¤ÆÚ£¬·ÖÀàΪBRCA1, BRCA2, ºÍBRCAX¡£±ðµÄ£¬ Óö¨Á¿PCRÆÊÎöÁË198ÀýÒÅ´«ÐÔÈéÏÙ°©²¡ÈËÍâÖÜѪ°×ѪÇòÖÐDNA¶ËÁ£µÄ³¤¶È£¬²¢Óë267Àý±ÈÕÕÑù±¾ºÍ71Àýż·¢µÄÈéÏÙ°©²¡ÈËÑù±¾¾ÙÐÐÁ˽ÏÁ¿¡£Í¬Ê±Ò²ÆÀ¹ÀÁËÈéÏÙ°©¼Ò×åĸŮ¶ÔºÍ±ÈÕÕÑù±¾µÄ¶ËÁ£³¤¶Èת±äÀ´Éó²é´ú¼ä²î±ð£¬·¢Ã÷¶ÌµÄ¶ËÁ£ÊÇÒÅ´«ÐÔ¶ø²»ÊÇż·¢ÐÔÈéÏÙ°©µÄÌØÕ÷¡£ËûÃÇÈ·¶¨ÁËÒ»×é´øÓж̶ËÁ£µÄÈéÏÙ°©¼Ò×åBRCAX£¬ÌáÐѶËÁ£Î¬»¤»ùÒò¿ÉÄÜÊÇÈéÏÙ°©µÄÃô¸Ð»ùÒò¡£ÖµµÃ×¢ÖØµÄÊÇ£¬ËûÃÇÐÎòÁ˶ËÁ£µÄ½¥½øÐÔËõ¶ÌÓëÊÜÓ°Ïì¼Ò×åÒ»Á¬´«´úʱÈéÏÙ°©µÄÔ½À´Ô½Ô籬·¢ÓÐÁªÏµ£¬²¢Îª´ËÌṩÁËÖ¤¾Ý£¬ÌáÐÑÕâ¿ÉÄÜÊÇÒÅ´«ÐÔÈéÏÙ°©ÒÅ´«Ô¤ÆÚµÄ»úÀí¡£
¡¾µãÆÀ¡¿
¸ÃÑо¿·¢Ã÷Á˶ËÁ£Òì³£ÓëÒÅ´«ÐÔÈéÏÙ°©Ö®¼äµÄ¹ØÁª£¬¼´Ô½À´Ô½¶ÌµÄ¶ËÁ£ÓëÔ½À´Ô½Ô籬·¢ÒÅ´«ÐÔÈéÏÙ°©Ö®¼äÓйØÁª¡£
¡¾²Î¿¼ÂÛÎÄ¡¿PLoS Genetics, 2011; 7 (7): e1002182 DOI:10.1371/journal.pgen.1002182
Genetic Anticipation Is Associated with Telomere Shortening in Hereditary Breast Cancer
Beatriz Martinez-Delgado, Kira Yanowsky, Lucia Inglada-Perez, et al.
There is increasing evidence suggesting that short telomeres and subsequent genomic instability contribute to malignant transformation. Telomere shortening has been described as a mechanism to explain genetic anticipation in dyskeratosis congenita and Li-Fraumeni syndrome. Since genetic anticipation has been observed in familial breast cancer, we aimed to study telomere length in familial breast cancer patients and hypothesized that genetic defects causing this disease would affect telomere maintenance resulting in shortened telomeres. Here, we first investigated age anticipation in mother-daughter pairs with breast cancer in 623 breast cancer families, classified as BRCA1, BRCA2, and BRCAX. Moreover, we analyzed telomere length in DNA from peripheral blood leukocytes by quantitative PCR in a set of 198 hereditary breast cancer patients, and compared them with 267 control samples and 71 sporadic breast cancer patients. Changes in telomere length in mother-daughter pairs from breast cancer families and controls were also evaluated to address differences through generations. We demonstrated that short telomeres characterize hereditary but not sporadic breast cancer. We have defined a group of BRCAX families with short telomeres, suggesting that telomere maintenance genes might be susceptibility genes for breast cancer. Significantly, we described that progressive telomere shortening is associated with earlier onset of breast cancer in successive generations of affected families. Our results provide evidence that telomere shortening is associated with earlier age of cancer onset in successive generations, suggesting that it might be a mechanism of genetic anticipation in hereditary breast cancer.
5. ÈËÌåÓÕµ¼¶àÐÑĿϸ°û²ØÓÐÖ²¡ÐÔÏßÁ£ÌåDNAÍ»±ä
¡¾¶¯Ì¬¡¿
ÈËÌåÓÕµ¼¶àÐÑĿϸ°û×î½ü±»·¢Ã÷»á²ØÓлùÒò×éÐ޸쬵«ÖØ×éϸ°ûÏßÁ£ÌåDNAµÄÍêÕûÐÔ»¹Ã»ÓÐÑо¿¡£ÏßÁ£ÌåDNAÍ»±äÂʺܸߣ¬±»ÒÔΪ¶ÔÐí¶àÈËÌå¼²²¡¸ºÓÐÔðÈΡ£²¢ÇÒ£¬ÏßÁ£ÌåDNAʧȥÍêÕûÐÔ¿ÉÄÜ»á¸Ä±äϸ°ûµÄÄÜÁ¿´úл£¬ÏÞÖÆÏ¸°û·Ö½â¡£ÒÔǰ֤ʵÎúÓÕµ¼¶àÐÑĿϸ°ûµÄ±¬·¢ÓëÏßÁ£ÌåÖØ¹¹ºÍÏòÌǽâ´úлת»»ÓйصÄÒ»¸öµÂ¹úÑо¿×é×î½üÓֲⶨÁËϸ°ûÖØ×é¶ÔÏßÁ£ÌåDNAµÄÍêÕûÐÔµÄÓ°Ïì¡£Õë¶ÔÏßÁ£ÌåDNAµÄ´ó¹æÄ£Æ½Ðн¹Á×Ëá²âÐòÏÔʾȪԴÓÚÄêÇ῵½¡¹©ÌåµÄÈËÌåÓÕµ¼¶àÐÑĿϸ°û²ØÓе¥¸ö¼î»ùµÄÏßÁ£ÌåDNAÍ»±ä£¨Ìæ»»¡¢²åÈ롢ɾ³ý£©£¬¼ÈÓÐͬÖʵģ¨ÔÚËùÓÐÏßÁ£ÌåDNA·Ö×Ó£©ÓÖÓÐÒìÖʵģ¨ÔÚÒ»²¿·ÖÏßÁ£ÌåDNA·Ö×Ó£©¡£ÓÐȤµÄÊÇ£¬ÒìÖÊÐÔˮƽÔÚȪԴÓÚͳһ¸¸´úÏËάĸϸ°ûµÄÓÕµ¼¶àÐÑĿϸ°ûϵ¼äÒ²¸÷²»Ïàͬ£¬ÕâÒ»Õ÷ÏóºÜ¿ÉÄÜ¿ÉÓÃÓÚ¿ª±¬·¢²úȪԴÓÚÏßÁ£Ìå¼²²¡»¼ÕßµÄÎÞÏßÁ£ÌåDNAÍ»±äµÄÓÕµ¼¶àÐÑĿϸ°û¡£Í¨¹ýÕûºÏת¼¡¢´úлºÍÓÐÓõÄÉúÎïÄÜÁ¿Ñ§¼¸·½ÃæµÄÊý¾Ý£¬¸ÃÑо¿Õ¹ÏÖÁË´øÓвî±ðˮƽÏßÁ£ÌåDNAÍ»±äµÄÓÕµ¼¶àÐÑĿϸ°ûϵά³ÖÁ˺㶨µÄÈËÌåÅßÌ¥¸Éϸ°ûÑùµÄÄÜÁ¿´úÐ»ÖØ×é¡£Õâ°üÀ¨¹ý±í´ïÌǽâø£¬ÔöÌíG6PµÄÁ¿£¬¸ß±í´ïPDK1ÂѰף¬´Ó¶ø½«ÉúÎïÄÜÁ¿Á÷Ïß·תÏòÌǽ⡣×ÜÖ®£¬Ö»¹ÜÓÕµ¼¶àÐÑĿϸ°ûÖеÄÏßÁ£ÌåDNAÍ»±ä²»Ó°ÏìÖØ×éÏà¹ØµÄ´úлµ÷½â£¬ÔÚÆÊÎöÓÕµ¼¶àÐÑĿϸ°ûϵʱÖ²¡ÐÔÏßÁ£ÌåDNAÐÞÊεķºÆðÕÕ¾ÉÒª¼à¿ØµÄÒ»¸öÖ÷Òª·½Ãæ¡£
¡¾µãÆÀ¡¿
ÓÕµ¼¶àÐÑĿϸ°ûÖеÄÏßÁ£ÌåDNAÍ»±äËä²»Ó°ÏìÖØ×éϸ°ûµÄ´úлõè¾¶µ÷½â£¬µ«ÒÀÈ»±£´æ½ÏÁ¿¸ßµÄÖ²¡Î£º¦£¬´ó´óÏÞÖÆÁË×ÅÊÊÓÃÐÔ¡£
¡¾²Î¿¼ÂÛÎÄ¡¿Stem Cells, 2011; DOI:10.1002/stem.683
Human iPSCs Harbor Homoplasmic and Heteroplasmic Mitochondrial DNA Mutations While Maintaining hESC-Like Metabolic Reprogramming
Alessandro Prigione, Björn Lichtner, Heiner Kuhl, et al.
Human induced pluripotent stem cells (iPSCs) have been recently found to harbor genomic alterations. However, the integrity of mitochondrial DNA (mtDNA) within reprogrammed cells has yet to be investigated. mtDNA mutations occur at a high rate and are believed to contribute to the pathology of a number of human disorders. Furthermore, lack of mtDNA integrity may alter cellular bioenergetics and limit efficient differentiation. We previously demonstrated that the derivation of iPSCs is associated with mitochondrial remodeling and a metabolic switch towards glycolysis. Here, we aimed to determine the consequences of reprogramming on mtDNA integrity. Massively parallel pyrosequencing of mtDNA revealed that human iPSCs derived from young healthy donors harbored single base mtDNA mutations (substitutions, insertions, and deletions), both homoplasmic (in all mtDNA molecules) and heteroplasmic (in a fraction of mtDNAs). Interestingly, the level of heteroplasmy varied among iPSC lines derived from the same parental fibroblasts. This phenomenon could potentially be exploited for the generation of mtDNA mutation-free iPSCs from patients with mtDNA disorders. By integrating transcriptional, metabolic, and functional bioenergetic data, we unveiled that iPSC lines bearing different mtDNA mutational loads maintained a consistent hESC-like reprogramming of energy metabolism. This included over-expression of glycolytic enzymes, increased amount of G6P, and elevated protein expression of PDK1, which re-routes the bioenergetic flux towards glycolysis. Overall, although the mtDNA mutations within our iPSCs did not affect the reprogramming-associated metabolic modulation, the occurrence of pathogenic mtDNA modifications might be an important aspect to monitor when characterizing iPSC lines.